Pediatric Brain Tumor Recruiting Phase 1 Trials for Filgrastim (DB00099)

IndicationStatusPhase
DBCOND0059839 (Pediatric Brain Tumor)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03434262SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain TumorsTreatment